Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
  • Y2021
R&D InsightY2018

FORWARD Act For Antifungals, NTAP Achaogen And Melinta, Novo REPAIR Funding Round

Dear All: I hope your summer is going well! Below, three items of interest. See as well several updates to …

Read More >
R&D InsightY2018

Potpourri: Help design ASM Microbe 2019; IACG consultancy; JLME issue on antibiotic incentives

Dear All: Three things today — see list below. And if you’ve not heard, it looks like REVAMP (the US …

Read More >
R&D InsightY2018

REVAMP, a pull incentive in the US: Time to make it happen!

Dear All: I previously wrote about the nascent REVAMP legislation that would create a Pull incentive in the US market. With everybody …

Read More >
R&D InsightY2018

Approaches to antifungal R&D: A lecture from ISHAM

Dear All: ISHAM 2018, the meeting of the International Society for Human and Animal Mycology, is now happening in Amsterdam. …

Read More >
R&D InsightY2018

Heads-up on REVAMP, a credible Pull incentive for the US!

Dear All: Incredibly exciting news! Due to the bipartisan efforts of Representatives John Shimkus (R-IL) and Tony Cardenas (D-CA), the Re-Valuing Anti-Microbial …

Read More >
R&D InsightY2018

Listen & learn: A pair of FDA Advisory committees and a webinar on PK-PD

Dear All: New things continue to appear at a furious pace! Here are 3 excellent opportunities to listen and learn. …

Read More >
R&D InsightY2018

21-22 Aug 2018 FDA workshop: Development of Non-Traditional Therapies for Bacterial Infections

Dear All: Following hard on the heels of yesterday’s note about the 14 June 2018 Duke-Margolis workshop on development of non-traditional products, …

Read More >
R&D InsightY2018

Concept papers for comment: EMA Antibacterial Guidance + IACG global action action

Dear All: Also appearing today are two valuable opportunities to comment on key global strategy documents. I do hope each of …

Read More >
R&D InsightY2018

14 June Duke-Margolis workshop on non-traditional products: Post-meeting materials

Dear All: I wrote previously about the Duke-Margolis workshop done in collaboration with FDA on the challenges of developing non-traditional antimicrobial products. …

Read More >
R&D InsightY2018

FDA LPAD guidance + Comments on incentives in Commissioner Gottlieb’s accompanying press release!

Dear All: FDA has today released an initial draft of its guidance on LPAD (Limited Population Pathway for Antibacterial and Antifungal Drugs). You may …

Read More >
R&D InsightY2018

BARDA’s DRIVe goes live; FDA workshop (27 Jun!) on inhaled antibiotics

Dear All: I don’t mean to inundate your inbox (this is my 3rd email this week!), but these two things …

Read More >
IncentivesY2018

Encouraging a Pull incentive in the US: Now is the time for a note from you or your company

Dear All: You are doubtless now familiar with all the reasons why we need pull incentives for AMR-related products (as background, …

Read More >
IncentivesY2018

NIAID Funding opportunity + FDA guidance x 3: revisions for cIAI and cUTI + new for uUTI (draft)

Dear All: First up, NIAID has released a BAA (Broad Agency Announcement) regarding up to $15.5m in funds for awards in two research …

Read More >
IncentivesY2018

CARB-X receives $50m from UK & Gates; Session at BIO on antibiotic reimbursement; PLOS opens an AMR Channel; CDD-sponsored SAR webinar

Dear All: There has been tremendously exciting activity in parallel with this week’s World Health Assembly! Here’s the list… CARB-X has announced …

Read More >
R&D InsightY2018

Meetings galore! AMR Awareness (Geneva), EMA information day for SMEs, One Health, CNS infections, and clinical trial methodology

Dear All: There are days when I have the feeling of drinking from a fire hose … and this is …

Read More >
R&D InsightY2018

14 June Duke-Margolis workshop + A taxonomy for non-traditional (non-Fleming) antimicrobials

Dear All: (18 June addendum: the materials from the meeting are now posted!) First, planning continues apace for the 14 June Duke-Margolis workshop on non-traditional …

Read More >
Media & GraphicsY2018

Superb Book To Read & Share: “Superbugs, An Arms Race Against Bacteria”

Dear All: I would like to draw your attention to a superb new book by William Hall, Anthony McDonnell, and Jim …

Read More >
R&D InsightY2018

Treating CNS infections: An NIH/DoD workshop on strategies for crossing the blood-brain barrier

Dear All: Sponsored by NIH (NIAID, NINDS, NHLBI, NCATS) and DoD (DTRA), a 2-day workshop on CNS infections and ways …

Read More >
IncentivesY2018

JPIAMR: Network proposal call; BARDA: DRIVe Accelerator call

Dear All: I trust you are now home after ECCMID in Madrid … it was an excellent meeting. Two new …

Read More >
R&D InsightY2018

ECCMID Symposium: Expediting antibacterial development: core lessons and key tools for a rocky road

Dear All: GARDP and CARB-Xed co-sponorsored yesterday an ECCMID symposium entitled “Expediting antibacterial development: core lessons and key tools for a rocky road.” …

Read More >
Scroll to Top